0.02 is a given. They are selling shares to get 10 Mil to start phase 1 and have been given a 1 Bil + valuation if drug proves out. They are also listing on TSX-V in Canada. All hugely positive news and insiders (and other companies) hold majority of shares. We will see 0.05-0.10 sooner than later. IMO